 |
市場調查報告書
商品編碼
1767687
眼部保健品市場：依成分類型、適應症類型、劑型類型、通路及地區分類Eye Health Supplements Market, By Ingredients Type, By Indication Type, By Dosage Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025 年眼部保健補充劑市場規模估計為 32.571 億美元，預計到 2032 年將達到 54.745 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.7%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 32.571億美元 |
| 效能數據 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年複合年成長率： | 7.70% | 2032年價值預測 | 54.745億美元 |
由於螢幕使用時間和數位設備接觸時間的增加，眼部健康問題日益受到關注。常見的眼睛問題包括眼睛疲勞、眼乾、眼紅、眼睛刺激和流淚。此外，常見的眼部疾病包括老齡化黃斑部病變(AMD)、白內障和青光眼。老齡化黃斑部病變是一種會隨著時間的推移而惡化的眼部疾病。雖然這種疾病不會導致失明，但會導致嚴重的視力問題。眼部疾病的主要症狀包括視力模糊和色覺障礙。
白內障是指水晶體變得混濁，導致視力模糊、混濁和變色。白內障的主要症狀包括視力模糊、複視和夜間視力下降。青光眼是一種損害視神經的眼部疾病。青光眼與眼壓升高有關。眼壓升高會損害視神經。如果損害嚴重，青光眼會導致永久性視力喪失。青光眼的主要症狀包括眼睛充血、眼痛和燈光周圍的暈光感。醫生會開一些含有葉黃素、玉米黃質、 Omega-3脂肪酸、維生素 A、BETA-胡蘿蔔素和越橘萃取物等成分的藥物，用於治療白內障、青光眼等眼部疾病。
市場動態
預計監管機構核准新產品將在預測期內推動全球眼部保健補充劑市場的成長。例如，2023年3月7日，專注於開發眼部護理產品的生物製藥公司NovaBay Pharmaceuticals, Inc.推出了Avenova眼部健康支援產品，這是一款富含抗氧化劑的新型口服補充劑，可緩解眼部乾澀並促進整體眼部健康。
本研究的主要特點
- 本報告對全球眼部保健補充劑市場進行了詳細分析，以 2024 年為基準年，預測了 2025 年至 2032 年期間的市場規模。
- 它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 它根據公司概況、業績、產品系列、地理位置、分銷策略、關鍵發展和策略等參數，介紹了全球眼部保健補充劑市場的主要企業概況。
- 本報告的見解將使企業負責人和經營團隊能夠就未來的產品發布、政府舉措、技術升級、市場擴張和行銷策略做出明智的決策。
- 本研究報告針對該行業的各個相關人員，例如全球眼部保健補充劑市場的投資者、產品製造商、經銷商、供應商、研究公司、諮詢公司、新進業者和金融分析師。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 市場機會
- 影響分析
- 最新產品發布
- 流行病學
- 合併、收購和合作
- 監管情景
- 主要進展
- PEST分析
4. 2020-2032 年全球眼部保健補充品市場（依成分類型）
- 葉黃素和玉米黃質
- Omega-3脂肪酸
- 維生素A
- BETA-胡蘿蔔素
- 越橘萃取物
- 其他
5. 2020 年至 2032 年全球眼部保健補充品市場（依適應症類型分類）
- 老齡化黃斑部病變（AMD）
- 白內障
- 乾眼症
- 青光眼
- 其他
6. 全球眼部保健補充品市場（依配方類型），2020-2032 年
- 錠劑
- 膠囊
- 軟膠囊
- 其他
7. 全球眼部保健補充品市場（依通路分類），2020-2032 年
- 醫院藥房
- 零售藥局
- 網路藥局
8. 2032 年全球眼部保健補充品市場（按地區）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第9章 競爭態勢
- Pfizer Inc
- Bausch Health Companies Inc
- Alcon
- Alliance Pharma PLC
- Allied Biotech Corporation
- BASF SE
- Amway India Enterprises Pvt. Ltd
- Butterflies Healthcare Ltd
- Herbalife International, Inc
- Nordic Naturals
- Vitabiotics Ltd
- Akorn Operating Company LLC
第 10 章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI3791
Eye Health Supplements Market is estimated to be valued at USD 3,257.1 Mn in 2025 and is expected to reach USD 5,474.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,257.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.70% | 2032 Value Projection: | USD 5,474.5 Mn |
Eye health is a growing concern owing to increased screen time and digital exposure. Common eye problems include eye strain, dry and red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include Age-related Macular Degeneration (AMD), cataract, and glaucoma. Age-related macular degeneration is an eye disease that gets severe over time. The disease does not cause blindness but can cause severe vision-related problems. Some of the major symptoms of eye problems are less clear vision and worse colour perception.
Cataract occurs when the natural lens of eyes become cloudy. Proteins present in the eyes break down and this causes things to look blurry, hazy, or less colourful. Some of the major symptoms of cataract are blurry vision, seeing double objects, and having trouble seeing at night. Glaucoma is an eye disease that damages eye's optic nerve. Glaucoma is related to the build up of pressure inside the eyes. The increased pressure can cause damage to the optic nerve. If the damage is severe glaucoma can cause permanent vision loss. Some of the major symptoms of glaucoma are redness in eyes, eye pain, and seeing halos around light. Doctors prescribe medicines for eye related diseases, such as cataract, glaucoma, and others, which include ingredients such as lutein and zeaxanthin, omega-3 fatty acids, vitamin A, beta-carotene, and bilberry extracts.
Market Dynamics
Approval of new products by regulatory bodies is expected to propel the global eye health supplement market growth during the forecast period. For instance, on March 7, 2023, NovaBay Pharmaceuticals, Inc, a biopharmaceutical company that develops products for the eye care market, launched Avenova Eye Health Support, a new antioxidant-rich oral supplement to comfort dry eyes and promote the overall eye health.
Key features of the study:
- This report provides an in-depth analysis of the global eye health supplements market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%) for the forecast period: 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global eye health supplement market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- The key players covered as a part of this study include: Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway Corp., Butterflies Healthcare Ltd, Herballife Nutrition Ltd., SUSS Technology Corp., Eyescience Labs, Nordic Naturals, Vitabiotics Ltd., and Akorn Incorporated
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global eye health supplement market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for the global eye health supplements market, research and consulting firms, new entrants, and financial analysts
Market Segmentation:
- Global Eye Health Supplements Market, By Ingredients Type:
- Lutein And Zexanthin
- Omega- 3 Fatty Acids
- Vitamin A
- Beta Carotene
- Bilberry Extracts
- Others
- Global Eye Health Supplements Market, By Indication Type:
- Age-related Macular Degeneration (AMD)
- Cataract
- Dry Eye Syndrome
- Glaucoma
- Others
- Global Eye Health Supplements Market, By Dosage Type:
- Tablets
- Capsules
- Soft Gels
- Others
- Global Eye Health Supplements Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Eye Health Supplements Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Bausch Health Companies Inc
- Alcon
- Alliance Pharma PLC
- Allied Biotech Corporation
- BASF SE
- Amway India Enterprises Pvt. Ltd
- Butterflies Healthcare Ltd
- Herbalife International, Inc
- Nordic Naturals
- Vitabiotics Ltd
- Akorn Operating Company LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Ingredients Type
- Market Snapshot, By Indication Type
- Market Snapshot, By Dosage Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trend Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Eye Health Supplements Market, By Ingredients Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Lutein and Zeaxanthin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Omega-3 Fatty Acids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Vitamin A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Beta - Carotene
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Bilberry Extracts
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
5. Global Eye Health Supplements Market, By Indication Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Age-related Macular Degeneration (AMD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Cataract
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Dry Eye Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
6. Global Eye Health Supplements Market, By Dosage Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Soft Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
7. Global Eye Health Supplements Market, By Distribution Channel, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
8. Global Eye Health Supplements Market, By Region, 2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alcon
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alliance Pharma PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allied Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BASF SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amway India Enterprises Pvt. Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Butterflies Healthcare Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Herbalife International, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nordic Naturals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vitabiotics Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Akorn Operating Company LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
